SPRO
Spero Therapeutics, Inc. · Healthcare
CEO and President Sath Shukla sold $43K of Spero Therapeutics, Inc.
Sold$42,646
$1.31Price
32,441Shares
−3%Stake
What SPRO did after the filing
- The stock from Tue, Aug 6 close, $1.27
- +5.5%
- S&P 500, same days
- +7.5%
Measured over 30 trading days, to the Sep 18 close.
Traded Fri, Aug 2. Filed Tue, Aug 6, 3:56 PM ET, during the session. Returns use the Aug 6 close and the Sep 18 close. Not investment advice.